Ensysce Biosciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $676.7K | $745.5K | $4.3M | $1.7M | $2.2M | $3.1M | $3.5M | $4.2M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $2.8M | $2.0M | $7.2M | $2.9M | $5.3M | $4.4M | $5.3M | $9.1M |
| Property, Plant & Equipment | $111.1K | $117.6K | $124.1K | $123.6K | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $3.0M | $2.2M | $7.5M | $3.2M | $5.6M | $4.6M | $5.6M | $9.4M |
| Liabilities | ||||||||
| Accounts Payable | $2.0M | $1.6M | $3.3M | $463.5K | $1.0M | $615.3K | $1.4M | $2.0M |
| Total Current Liabilities | $4.1M | $2.8M | $4.6M | $2.3M | $2.5M | $1.8M | $2.2M | $2.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.1M | $2.8M | $4.6M | $2.3M | $2.5M | $1.9M | $2.2M | $2.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-145.8M | $-143.3M | $-139.7M | $-137.0M | $-133.2M | $-131.5M | $-129.5M | $-126.0M |
| Total Stockholders' Equity | $-781.7K | $-340.0K | $3.2M | $1.2M | $3.4M | $3.0M | $3.7M | $6.9M |